|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| (11) | Number of the document | 4176894 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22181403.1 |
| Date of filing the European patent application | 2015-01-09 | |
| (97) | Date of publication of the European application | 2023-05-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-28 |
| (46) | Date of publication of the claims translation | 2024-06-10 |
| (30) | Number | Date | Country code |
| 201461926226 P | 2014-01-10 | US | |
| 201461988104 P | 2014-05-02 | US |
| (72) |
CHHABRA, Ekta, Seth , US
LIU, Tongyao , US
PETERS, Robert T. , US
KULMAN, John , US
|
| (73) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham MA 02451,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | VIII faktoriaus chimeriniai baltymai ir jų naudojimas |
| FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-12-04 | 12 | 289.00 EUR |
| 2027-01-09 |